which later expanded to 12,000 people. on 26 january, a volunteer in the placebo group of the trials had died from covid-19 related pneumonia. in september, argentina began trials with 3,000 people. in pakistan, university of karachi conducted a trial with 3,000 volunteers. authorizations full authorization emergency authorization allowed for travel eligible covax recipient